Abstract
Introduction
Estrogen (E2) signaling through estrogen receptors (ERα and ERβ) plays a pivotal role in normal growth and function of female reproductive system and in the pathogenesis of the majority of human breast cancers (1, 2) . ERs, members of the nuclear hormone receptor superfamily, function primarily through transcriptional control of gene expression, which is facilitated by nuclear co-regulator proteins (3) (4) (5) (6) (7) (8) (9) . E2 induction of genes such as cyclin D1 and c-myc in human breast cancer cells likely involves a coordinated recruitment and assembly of a large number of co-regulators (10) (11) (12) (13) . One model proposed for the assembly is protein-protein interaction-mediated docking. For instance, in addition to interacting with nuclear receptors, members of the p160/SRC family can also associate with other co-regulators such as p300/CBP and CARM1 (14) . Likewise, targeting of the ATP-dependent chromatin remodeling complexes and the Mediator complex to hormone-responsive genes appears to involve direct interactions between components of the complex and the receptors (15) (16) (17) . Evidence has also been presented that even though the coactivators may be sequentially recruited to chromatin they may function interdependently (18) , suggesting that hormone-induced recruitment of the different co-regulators and/or their assembly at the receptor target gene locus is a facilitated process. However, mechanisms underlying the facilitation are not defined.
AAA+ (ATPases associated with various cellular activities) proteins constitute a large family of evolutionarily conserved enzymes that appear to function by causing conformational changes in their substrate proteins or complexes (19) (20) (21) (22) . Some of the extensively studied, eukaryotic AAA+ proteins such as p97/VCP, NSF and dynein have diverse functions including membrane fusion, protein degradation, and microtubule sliding. Others such as RFC-PCNA complex and CDC6 are involved in the loading or assembly of multi-protein complexes in DNA replication (19) . These proteins contain one or more AAA+ domains 3 that are a sub-family of P-loop ATPases with the Walker-A and -B motifs. However, they differ from the other ATPases including the SNF2 family of chromatin remodeling helicases, in several structural and functional features (20) . The most salient feature is that AAA+ proteins usually function in an oligomeric form, where structural motif called arginine fingers from one subunit constitutes part of the nucleotidebinding site of an adjacent subunit.
Here we report the identification of ANCCA, a previously predicted AAA+ protein with a bromodomain, as a novel ERα coactivator with expression highly induced by E2. We provide evidence that ANCCA mediates E2-stimulated expression of key cell cycle regulators likely via its ATP-driven protein complex remodeling function and discuss potential implications for ANCCA in breast cancer.
Results

ANCCA, an evolutionarily conserved AAA+ protein, is a direct target of ACTR and is strongly induced by estrogen
We previously found that overexpression of ACTR promotes breast cancer cell proliferation and antiestrogen resistance. To further understand its functional mechanism, we performed gene expression microarray analysis of breast cancer cells overexpressing ACTR or treated with E2. Both array studies demonstrated up-regulation of an ORF called pro2000 or atad2 with two predicted AAA+ ATPase domains (AAA-D1 and AAA-D2) and a bromodomain. To reflect its function as described below and its link to cancer (below and see Discussion) as well as its recognizable domain feature, we designate this gene as AAA+ nuclear cofactor cancer associated, or ANCCA (Fig. 1A) . Interestingly, ANCCA orthologs with similar AAA+ and bromodomain composition can be found in the current database across the entire 4 eukaryotes (except D. melogaster, Supporting information (SI) Fig. 7A ). However, their biological functions are largely unknown. Ectopic ACTR induced the expression of ANCCA 4-fold over the control vector in T-47D cells rendered quiescent by anti-estrogen ICI182,780 (Fig. 1B) . Likewise, when the cells were treated with E2, ANCCA expression was also strongly induced. E2 induction can be readily detected as early as 6 hours after the treatment (SI Fig. 8A ). Northern blotting yielded similar results of E2-induced expression of ANCCA mRNA (5 kb and 4.7 kb mRNAs, Fig. 1C) . Notably, the non-malignant human mammary epithelial cell line MCF-10A expressed a relatively low level of ANCCA. Western blotting detected ANCCA protein with molecular weight of ~170 kD in the breast cancer cells, which was highly induced by E2 as early as 12 hrs after E2 addition (Fig. 1D ). Immuno-fluorescence study revealed ANCCA localized primarily in the nucleus (SI Fig 8B) . Chromatin immunoprecipitation (ChIP) assay with anti-ACTR antibody detected a specific occupancy of ACTR at the predicted transcription start region of ANCCA, indicating that ACTR directly controls ANCCA expression (SI Fig. 8C ).
ANCCA is required for estrogen-induced cell proliferation and cell cycle progression
Our finding that ANCCA is regulated by E2 prompted us to examine its function in E2-stimulated cell proliferation. We thus performed RNAi knockdown experiments and assessed the effect on cell proliferation. Adenovirus vector-mediated expression of a sh-RNA sequence against ANCCA specifically suppressed its expression in T-47D cells with a strong silencing effect observed 2 days after the adenovector treatment ( Fig. 2A , Gi, GFP-RNAi and Ai, ANCCA-RNAi). Remarkably, knocking down ANCCA was highly inhibitory to E2-stimulated proliferation of T-47D cells (Fig. 2B) . Similarly, transfection of MCF-7 cells with a synthetic siRNA targeting a different region of ANCCA mRNA also resulted in strong inhibition of E2-stimulated cell proliferation (SI Fig. 9A ), indicating that the effect of ANCCA RNAi on proliferation is not cell-specific or due to a particular siRNA sequence. To assess the potential mechanistic defect underlying the observed effect on cell proliferation, we examined the cell cycle profile. MCF-7 cells transfected with siRNA were treated with E2 for 24 hours before harvesting for flow cytometry analysis. As expected from a previous study that a primary effect of E2 is to stimulate G1-S transition, in control siRNA transfected cells, E2 increased S-phase cells from 15% to about 48% (thus 33% net increase of cell population in S phase). In contrast, in ANCCA siRNA transfected cells, E2 caused about 14% increase in S phase (SI Fig. 9B ). These results indicate that depletion of ANCCA strongly impedes E2-dependent cell cycle progression from G1 to S. Taken together, these results suggest that ANCCA plays a critical role in E2-stimulated proliferation of human breast cancer cells and that one of the mechanisms is promoting G1-S transition.
ANCCA is recruited to selective ERα target genes and is required for their induced expression
Previous studies demonstrated that E2-stimulated breast cancer cell proliferation involves ERα-mediated direct control of the expression of key cell cycle regulatory genes (23) (24) (25) (26) . Since ANCCA is a nuclear protein with a bromodomain, which is often found in chromatin/transcriptional regulators, it is possible that ANCCA plays a role in transcriptional regulation mediated by ERα. As shown in Figure 3A , depletion of ANCCA almost completely blocked E2 induction of cyclin D1, c-myc and E2F1 mRNA. Remarkably, E2-induced pS2 and cathepsin D transcripts were not significantly affected (Fig. 3A and data not shown).
Consistent with the mRNA analysis, Western blotting demonstrated that ANCCA depletion resulted in significant decrease of cyclin D1 and E2F1 proteins (Fig. 3B ).
To examine whether ABCCA is directly involved in ER-mediated control of transcription we performed ChIP analysis. As shown previously (10) (11) (12) , treating cells with E2 induced a robust recruitment of ERα and coactivator ACTR at the ER target gene promoter region of cyclin D1, c-myc, E2F1 and pS2 (Fig. 4A ).
Strikingly, in the same ChIP experiment, anti-ANCCA antibody detected strong E2-induced recruitment/occupancy of ANCCA at 1 hr and 6 hr of E2 treatment at the same regions of cyclin D1, E2F1 and c-myc genes where ERα and ACTR occupy. However, on pS2 promoter, no significant recruitment/occupancy of ANCCA was detected under the same condition (Fig. 4A , the right panel), which is consistent with the data that ANCCA depletion did not significantly affect pS2 gene expression. Together, these results strongly suggest that ANCCA is directly involved in estrogen induction of a specific subset of ERα target gene expression.
ANCCA is required for estrogen induction of CBP recruitment and chromatin histone hyperacetylation
To further investigate the functional mechanism of ANCCA, we first examined the effect of its depletion on two of the fundamental activities at chromatin in ERα-mediated gene expression, i.e. E2-induced ERα recruitment to target genes and histone hyperacetylation. Notably, depletion of ANCCA had no significant effect on E2-induced ERα recruitment at the ERα target genes examined (Fig. 4 , B-D, left panels). In contrast, ANCCA depletion dramatically suppressed E2-induced histone H4 acetylation at the proximal promoter region of cyclin D1, c-myc and E2F1 (Fig. 4 , B-D, right panels). Since CBP play crucial roles in estrogen-induced histone hyperacetylation, we next examined whether CBP occupancy is affected by ANCCA depletion. Strikingly, its depletion strongly inhibited E2-induced CBP occupancy on all three promoters ( Fig. 4E, 3 -5 fold decrease). Together, these results suggest that, although ANCCA may not be critical for ERα recruitment to its target genes, it plays an important role in the recruitment or assembly of ERα-CBP complex at the chromatin and hence the histone modifications mediated by the complex.
ANCCA directly interacts with ERα and ACTR
To gain further insight into the mechanism of ANCCA action, we next asked whether ANCCA physically associates with ERα or coactivators such as ACTR. Therefore, we first performed co-immunoprecipitation Interestingly, a strong association between ANCCA and ACTR was also detected by the co-IP. To examine whether ANCCA directly interacts with ERα and ACTR, we performed GST pull-down assay with purified recombinant proteins (Fig. 5B) . We found that GST-ERα, but not GST (data not shown) or irrelevant GSTRas, was able to pull down ANCCA, indicating specific and direct interactions between ERα and ANCCA.
Notably, the interaction is significantly enhanced by E2. Interestingly, GST-ACTR protein (aa493-C with N-terminus truncated), but not GST-ACTR-RID (receptor interaction domain, aa621-821) specifically pulled down ANCCA, suggesting that ACTR may interact with ANCCA and ERα via distinct domains.
ANCCA possesses ATPase activity
Based on their AAA+ domain sequence homology, AAA+ proteins can be divided into different groups (20) . Our sequence analysis indicates that the two AAA+ modules of ANCCA, particularly AAA-D1, share significant homology with that of the so-called classic clade of AAA+ proteins which include p97/VCP/Cdc48, Hsp104 and NSF. Not only is the five key sequence motifs for ATP binding and/or hydrolysis (Walker A and B, sensor 1 and 2, and arginine finger) and oligomerization (arginine finger) essentially identical to those of p97/VCP, but the sequences between the motifs are also highly conserved (SI Fig. 7B ). Therefore, we examined whether ANCCA binds to ATP and possesses ATPase activity using purified recombinant proteins. As expected, full-length ANCCA displayed specific ATP binding activity 8 while androgen receptor protein that was expressed and purified similarly showed no detectable ATP binding (Fig. 6A) . Consistent with the ATP binding results, we found that ANCCA protein showed strong ATPase activity with an approximate specific activity of 1 μmol/h/mg, which is comparable to other AAA+ proteins (20) . In contrast, ACTR and AR proteins showed no significant ATPase activity (Fig. 6B and data not shown).
The ATPase is important for ANCCA to mediate estrogen-stimulation of gene expression
Consistent with the notion that ANCCA is a coactivator of ERα, co-expression of ERα with wild type ANCCA resulted in a markedly increased E2 response (28 fold in ERα+ANCCA versus 5 fold in ER alone) of ERE-tk-luciferase reporter activity ( μl/ml, and anti-ANCCA antibody at 2 μg/ml. Precipitated DNA were reverse cross-linked overnight at 65°C, purified and analyzed as previously described (46) . 
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